Wegovy improves glycaemic control through multiple mechanisms, and these benefits diminish as the medication clears
West J, Li M, Wong S, Le GH, Teopiz KM, Valentino K, Dri CE, McIntyre RS (2025) Are Glucagon-Like Peptide-1 (GLP-1) receptor agonists Central Nervous System (CNS) penetrant: a narrative review
The opioid growth factor connection: LDN and endogenous peptides Low-dose naltrexone (LDN) is not a peptide itself, but its mechanism of action revolves entirely around endogenous peptide systems
Sublingual formulations are liquid drops placed under the tongue
Supplementation is often necessary to achieve optimal levels
This nuance gets lost in social media discussions where the minority with severe reactions post repeatedly, creating false impression of universal suffering